Autolus Therapeutics Correlations

AUTL Stock

USD 3.32 0.05 1.53%

The current 90-days correlation between Autolus Therapeutics and Cullinan Oncology LLC is 0.18 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Autolus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Autolus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Autolus Therapeutics Correlation With Market

Weak diversification

The correlation between Autolus Therapeutics and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Autolus Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Autolus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Autolus Stock please use our How to buy in Autolus Stock guide.

Moving together with Autolus Stock

0.72	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.76	LLY	Eli Lilly	Pair Corr
0.74	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.7	RDY	Dr Reddys Laboratories	Pair Corr
0.62	AMGN	Amgen Inc	Pair Corr

Moving against Autolus Stock

0.63	VTRS	Viatris	Pair Corr
0.58	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.55	WAT	Waters	Pair Corr
0.38	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.35	GILD	Gilead Sciences	Pair Corr
0.5	MNMD	Mind Medicine	Pair Corr
0.42	NBIX	Neurocrine Biosciences	Pair Corr
0.4	BSX	Boston Scientific Corp Sell-off Trend	Pair Corr
0.39	DXCM	DexCom Inc Sell-off Trend	Pair Corr

Related Correlations Analysis

	CGEM	BOLT	DAWN	LYRA	ABOS	XFOR	INZY	VECT	TERN	AMLX
CGEM		0.54	0.25	0.83	0.22	0.86	0.86	-0.69	0.69	-0.66	CGEM
BOLT	0.54		0.3	0.62	0.45	0.37	0.46	-0.19	0.08	-0.15	BOLT
DAWN	0.25	0.3		0.33	0.72	0.17	0.09	0.35	0.04	0.47	DAWN
LYRA	0.83	0.62	0.33		0.44	0.83	0.69	-0.54	0.54	-0.42	LYRA
ABOS	0.22	0.45	0.72	0.44		0.13	0.06	0.37	-0.11	0.49	ABOS
XFOR	0.86	0.37	0.17	0.83	0.13		0.81	-0.76	0.82	-0.66	XFOR
INZY	0.86	0.46	0.09	0.69	0.06	0.81		-0.67	0.76	-0.73	INZY
VECT	-0.69	-0.19	0.35	-0.54	0.37	-0.76	-0.67		-0.72	0.92	VECT
TERN	0.69	0.08	0.04	0.54	-0.11	0.82	0.76	-0.72		-0.67	TERN
AMLX	-0.66	-0.15	0.47	-0.42	0.49	-0.66	-0.73	0.92	-0.67		AMLX
	CGEM	BOLT	DAWN	LYRA	ABOS	XFOR	INZY	VECT	TERN	AMLX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AMLX	+ 0.92	VECT
XFOR	+ 0.86	CGEM
INZY	+ 0.86	CGEM
LYRA	+ 0.83	CGEM
XFOR	+ 0.83	LYRA
TERN	+ 0.82	XFOR

High negative correlations

VECT	- 0.76	XFOR
AMLX	- 0.73	INZY
TERN	- 0.72	VECT
VECT	- 0.69	CGEM
AMLX	- 0.67	TERN
VECT	- 0.67	INZY

Risk-Adjusted Indicators

There is a big difference between Autolus Stock performing well and Autolus Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Autolus Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CGEM	2.89	(0.71)	0.00	(0.21)	0.00	0.00	5.88	(7.24)	17.85
BOLT	1.77	(0.12)	0.00	(0.46)	0.00	0.00	4.84	(4.48)	14.96
DAWN	2.06	(0.09)	(0.04)	0.01	2.77	(1.91)	3.84	(3.69)	11.44
LYRA	4.22	(0.60)	0.00	(0.31)	0.00	0.00	10.53	(10.00)	41.07
ABOS	3.54	(0.56)	0.00	(0.07)	0.00	0.00	7.52	(6.78)	28.07
XFOR	5.02	(0.47)	0.00	(0.22)	0.00	0.00	8.82	(10.61)	62.35
INZY	2.76	(1.22)	0.00	(0.59)	0.00	0.00	5.07	(7.92)	16.62
VECT	2.63	1.03	0.54	1.79	0.88	(3.64)	5.61	(3.08)	39.30
TERN	3.37	(0.33)	0.00	(0.22)	0.00	0.00	6.02	(5.96)	34.09
AMLX	4.36	1.48	0.30	1.40	4.11	(5.11)	10.06	(6.13)	33.56

Autolus Therapeutics Corporate Management

Olivia Manser	Director Relations	Profile
David Brochu	Senior Officer	Profile
Chris Williams	Senior Development	Profile
Robert Dolski	Chief Officer	Profile
Lucinda Crabtree	Chief Officer	Profile
Alexander Swan	Senior Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC